CA4 and cholangiocarcinoma: In the present study, our results showed that the KKU-213A spheroids were disrupted by the anti-MUC1-CAR4 T cells (Fig. 7), strongly suggesting the potential of the adoptive T cell therapy using anti-MUC1-CAR4 T cells in CCA.